Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Journal of hepatology

Results: 1-25/387

Authors: Lechmann, M Woitas, RP Langhans, B Kaiser, R Ihlenfeldt, HG Jung, G Sauerbruch, T Spengler, U
Citation: M. Lechmann et al., Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C, J HEPATOL, 31(6), 1999, pp. 971-978

Authors: Hezode, C Cazeneuve, C Coue, O Roudot-Thoraval, F Lonjon, I Bastie, A Duvoux, C Pawlotsky, JM Zafrani, ES Amselem, S Dhumeaux, D
Citation: C. Hezode et al., Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions, J HEPATOL, 31(6), 1999, pp. 979-984

Authors: Parquet, MD Yatsuhashi, H Koga, M Inoue, O Matsumoto, T Hamada, R Igarashi, A Yano, M
Citation: Md. Parquet et al., Prevalence and clinical characteristics of TT virus (TTV) in patients withsporadic acute hepatitis of unknown etiology, J HEPATOL, 31(6), 1999, pp. 985-989

Authors: Colombatto, P Brunetto, MR Kansopon, J Oliveri, F Maina, A Aragon, U Bortoli, ML Scatena, F Baicchi, U Houghton, M Bonino, F Weiner, AJ
Citation: P. Colombatto et al., High prevalence of G1 and G2 TT-virus infection in subjects with high and low blood exposure risk: identification of G4 isolates in Italy, J HEPATOL, 31(6), 1999, pp. 990-996

Authors: Nagaki, M Sugiyama, A Osawa, Y Naiki, T Nakashima, S Nozawa, Y Moriwaki, H
Citation: M. Nagaki et al., Lethal, hepatic apoptosis mediated by tumor necrosis factor receptor, unlike Fas-mediated apoptosis, requires hepatocyte sensitization in mice, J HEPATOL, 31(6), 1999, pp. 997-1005

Authors: Chardot, C Carton, M Spire-Bendelac, N Le Pommelet, C Golmard, JL Auvert, B
Citation: C. Chardot et al., Epidemiology of biliary atresia in France: a national study 1986-96, J HEPATOL, 31(6), 1999, pp. 1006-1013

Authors: Humaloja, K Roine, RP Vuoristo, M Farkkila, M Hockerstedt, K Salaspuro, M
Citation: K. Humaloja et al., Serum dolichols in chronic cholestatic liver diseases, J HEPATOL, 31(6), 1999, pp. 1014-1019

Authors: Eckhardt, ERM van Erpecum, KJ de Smet, MBM Go, PMNYH van Berge-Henegouwen, GP Renooij, W
Citation: Erm. Eckhardt et al., Lipid solubilization in human gallbladder versus hepatic biles, J HEPATOL, 31(6), 1999, pp. 1020-1025

Authors: Cruickshank, SM Southgate, J Selby, PJ Trejdosiewicz, LK
Citation: Sm. Cruickshank et al., Inhibition of T cell activation by normal human biliary epithelial cells, J HEPATOL, 31(6), 1999, pp. 1026-1033

Authors: Swart, PJ Hirano, T Kuipers, ME Ito, Y Smit, C Hashida, M Nishikawa, M Beljaars, L Meijer, DKF Poelstra, K
Citation: Pj. Swart et al., Targeting of superoxide dismutase to the liver results in anti-inflammatory effects in rats with fibrotic livers, J HEPATOL, 31(6), 1999, pp. 1034-1043

Authors: Aller, R Moya, JL Moreira, V Garcia-Lledo, A Sanroman, AL Paino, C Boixeda, D
Citation: R. Aller et al., Diagnosis and grading of intrapulmonary vascular dilatation in cirrhotic patients with contrast transesophageal echocardiography, J HEPATOL, 31(6), 1999, pp. 1044-1052

Authors: Reif, S Weis, B Aeed, H Gana-Weis, M Zaidel, L Avni, Y Romanelli, RG Pinzani, M Kloog, Y Bruck, R
Citation: S. Reif et al., The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats, J HEPATOL, 31(6), 1999, pp. 1053-1061

Authors: Regimbeau, JM Farges, O Shen, BY Sauvanet, A Belghiti, J
Citation: Jm. Regimbeau et al., Is surgery for large hepatocellular carcinoma justified?, J HEPATOL, 31(6), 1999, pp. 1062-1068

Authors: Laconi, S Curreli, F Diana, S Pasciu, D De Filippo, G Sarma, DSR Pani, P Laconi, E
Citation: S. Laconi et al., Liver regeneration in response to partial hepatectomy in rats treated withretrorsine: a kinetic study, J HEPATOL, 31(6), 1999, pp. 1069-1074

Authors: Martinez-Palli, G Barbera, JA Taura, P Cirera, I Visa, J Rodriguez-Roisin, R
Citation: G. Martinez-palli et al., Severe portopulmonary hypertension after liver transplantation in a patient with preexisting hepatopulmonary syndrome, J HEPATOL, 31(6), 1999, pp. 1075-1079

Authors: Kreymann, B Seige, M Schweigart, U Kopp, KF Classen, M
Citation: B. Kreymann et al., Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins, J HEPATOL, 31(6), 1999, pp. 1080-1085

Authors: Paumgartner, G
Citation: G. Paumgartner, Editor's full-term note, J HEPATOL, 31(6), 1999, pp. 1087-1087

Authors: Gentilini, P Laffi, G La Villa, G Romanelli, RG Blendis, LM
Citation: P. Gentilini et al., Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication?, J HEPATOL, 31(6), 1999, pp. 1088-1097

Authors: Schenker, S Martin, RR Hoyumpa, AM
Citation: S. Schenker et al., Antecedent liver disease and drug toxicity, J HEPATOL, 31(6), 1999, pp. 1098-1105

Authors: Riordan, SM Williams, R
Citation: Sm. Riordan et R. Williams, Tolerance after liver transplantation: does it exist and can immunosuppression be withdrawn?, J HEPATOL, 31(6), 1999, pp. 1106-1119

Authors: Marra, F
Citation: F. Marra, Hepatic stellate cells and the regulation of liver inflammation, J HEPATOL, 31(6), 1999, pp. 1120-1130

Authors: Uchimura, Y Uchimura, N Kumashiro, R Hattori, A Sata, M
Citation: Y. Uchimura et al., Changes in melatonin concentrations during IFN therapy, J HEPATOL, 31(6), 1999, pp. 1131-1131

Authors: Schindler, C Ramadori, G
Citation: C. Schindler et G. Ramadori, Albumin substitution improves urinary sodium excretion and diuresis in patients with liver cirrhosis and refractory ascites, J HEPATOL, 31(6), 1999, pp. 1132-1132

Authors: De Meyer, S Gong, ZJ Depla, E Maertens, G Yap, SH
Citation: S. De Meyer et al., Involvement of phosphatidylserine and non-phospholipid components of the hepatitis B virus envelope in human Annexin V binding and in HBV infection in vitro, J HEPATOL, 31(5), 1999, pp. 783-790

Authors: Rang, A Gunther, S Will, H
Citation: A. Rang et al., Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells, J HEPATOL, 31(5), 1999, pp. 791-799
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>